Yahoo
NSE - Delayed Quote INR

Sai Life Sciences Limited (SAILIFE.NS)

1,557.50 +61.80 (+4.13%)
At close: October 30 at 3:30:02 PM GMT+5:30
Chart Range Bar
Loading chart for SAILIFE.NS
  • Previous Close 1,495.70
  • Open 1,499.40
  • Bid --
  • Ask --
  • Day's Range 1,496.00 - 1,568.00
  • 52 Week Range 783.85 - 1,697.00
  • Volume 1,261,868
  • Avg. Volume 637,895
  • Market Cap (intraday) 330.926B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 92.00
  • EPS (TTM) 16.93
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 1,579.43

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.

www.sailife.com

5,224

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

SAILIFE.NS
71.46%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

SAILIFE.NS
69.23%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

SAILIFE.NS
139.62%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

SAILIFE.NS
139.62%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 5.54B
Earnings 732.85M
Profit Margin 13.22%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
2B
4B
6B
14.0%
15.0%
16.0%
17.0%
18.0%

Analyst Insights

View More

Analyst Price Targets

1,500.00 Low
1,579.43 Average
1,557.50 Current
1,620.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.08%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    22.5B

  • Net Income Avi to Common (ttm)

    3.62B

  • Diluted EPS (ttm)

    16.93

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.58B

  • Total Debt/Equity (mrq)

    11.61%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: